India Glycols · NSE: INDIAGLYCO · BSE: 500201

Q2 FY26 results · Jul–Sep 2025

India Glycols reported revenue from operations of ₹2,412.40 crore (up 12.5% from Q2 FY25) and net profit of ₹65.06 crore (up 30.9% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue from operations2,412.402,143.71+12.5%2,503.12−3.6%
Other income2.174.34−50.0%1.40+55.0%
Total income2,414.572,148.05+12.4%2,504.52−3.6%
Profit before share of associates & JVs and tax72.0552.64+36.9%71.91+0.2%
Share of profit/(loss) of associates & JVs11.5610.8218.62
Net profit for the period65.0649.71+30.9%73.25−11.2%
EPS, basic (₹)10.5116.06not comparable23.66not comparable
Net margin (%)2.72.32.9

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ2 FY26Q2 FY25YoYQ1 FY26QoQ
Revenue from operations2,410.712,143.63+12.5%2,503.03−3.7%
Other income2.174.34−50.0%1.40+55.0%
Total income2,412.882,147.97+12.3%2,504.43−3.7%
Profit before tax72.4953.20+36.3%70.13+3.4%
Net profit for the period53.9439.45+36.7%52.85+2.1%
EPS, basic (₹)8.7112.74not comparable17.07not comparable
Net margin (%)2.21.82.1
Consolidated
Filed with BSE
14 Nov 2025, 19:24 IST
Board meeting
14 Nov 2025
Period
01 Jul 2025 to 30 Sep 2025
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
14 Nov 2025, 19:24 IST
Board meeting
14 Nov 2025
Period
01 Jul 2025 to 30 Sep 2025
Review status
Unaudited
Source
XBRL filing on BSE